The application of Ropivacaine topical anesthesia through cricothyroid membrane during conscious tracheal intubation

Trans-cricothyroid membrane injection of ropivacaine on coughing and hemodynamics during intubation and extubation in maxillofacial patients

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-12002343

Enrollment

Unknown

Registered

2012-07-10

Start date

2012-04-22

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

maxillofacial surgery

Interventions

Group Ropivacaine:Ropivacaine topical anesthesia through cricothyroid membrane

2:1% Tetracaine 20mg

Eligibility

Sex/Gender

Female

Age

18 Years to 59 Years

Inclusion criteria

Inclusion criteria: 70 patients, 18–59 years of age, ASA I-II, who required general anaesthesia with nasotracheal intubation for maxillary and/or mandibular fracture surgery, were enrolled.

Exclusion criteria

Exclusion criteria: Patients who complicated with basal skull fracture, respiratory infection, nasal malformation, mental disorders, and smoking history and had gastroesophageal reflux, hiatal hernia, esophageal disease and pharyngeal and epiglottic tumors were excluded.

Design outcomes

Primary

Measure	Time frame
cough;blood pressure;	—

Countries

China

Contacts

Public ContactGao Wei

gaowei20055@126.com+86 13836172191

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026